- Home
- LXRX vs EVN Comparison
LXRX vs EVN Comparison
Compare LXRX & EVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXRX
- EVN
- Stock Information
- Founded
- LXRX 1995
- EVN 1998
- Country
- LXRX United States
- EVN United States
- Employees
- LXRX N/A
- EVN N/A
- Industry
- LXRX Biotechnology: Pharmaceutical Preparations
- EVN Investment Bankers/Brokers/Service
- Sector
- LXRX Health Care
- EVN Finance
- Exchange
- LXRX Nasdaq
- EVN Nasdaq
- Market Cap
- LXRX 428.8M
- EVN 433.2M
- IPO Year
- LXRX 2000
- EVN N/A
- Fundamental
- Price
- LXRX $1.13
- EVN $10.92
- Analyst Decision
- LXRX Buy
- EVN
- Analyst Count
- LXRX 5
- EVN 0
- Target Price
- LXRX $3.23
- EVN N/A
- AVG Volume (30 Days)
- LXRX 1.8M
- EVN 101.2K
- Earning Date
- LXRX 11-11-2025
- EVN 01-01-0001
- Dividend Yield
- LXRX N/A
- EVN 4.78%
- EPS Growth
- LXRX N/A
- EVN N/A
- EPS
- LXRX N/A
- EVN 0.34
- Revenue
- LXRX $58,432,000.00
- EVN N/A
- Revenue This Year
- LXRX N/A
- EVN N/A
- Revenue Next Year
- LXRX N/A
- EVN N/A
- P/E Ratio
- LXRX N/A
- EVN $29.94
- Revenue Growth
- LXRX 1504.83
- EVN N/A
- 52 Week Low
- LXRX $0.28
- EVN $8.64
- 52 Week High
- LXRX $2.18
- EVN $10.45
- Technical
- Relative Strength Index (RSI)
- LXRX 50.83
- EVN 67.47
- Support Level
- LXRX $1.03
- EVN $10.39
- Resistance Level
- LXRX $1.15
- EVN $11.01
- Average True Range (ATR)
- LXRX 0.06
- EVN 0.10
- MACD
- LXRX -0.01
- EVN 0.06
- Stochastic Oscillator
- LXRX 50.00
- EVN 84.92
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
About EVN Eaton Vance Municipal Income Trust
Eaton Vance Municipal Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax. The trust's portfolio of investments majorly consists of debt instruments of governments, municipal organizations the interest on which is exempt from regular federal income tax and has also some exposure to corporate bonds and other instruments.